• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童膀胱输尿管反流复发:内镜注射仍是最佳选择吗?

Recurrence of vesico-ureteral reflux in children: is still the endoscopic injection the best option?

作者信息

Nascimben Francesca, Talon Isabelle, Maldonado Consuelo, Angotti Rossella, Molinaro Francesco, Moog Raphael, Becmeur Francois

机构信息

Department of Pediatric Surgery, University Hospital of Hautepierre, Strasbourg, France.

Division of Pediatric Surgery, Department of Medical, Surgical and Neurological Sciences, University of Siena, Siena, Italy.

出版信息

Transl Androl Urol. 2024 Aug 31;13(8):1446-1454. doi: 10.21037/tau-24-76. Epub 2024 Aug 26.

DOI:10.21037/tau-24-76
PMID:39280646
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11399022/
Abstract

BACKGROUND

Endoscopic injection (EI) is a safe treatment for vesico-ureteral reflux (VUR) in children, but recurrences are not insignificant. This study aims to show if multiple EI is still the best first line management even if in case of recurrences.

METHODS

All patients affected by primary VUR, treated with at least one EI and with at least 5 years follow up were included. All general data were analyzed. Recurrence rate after one, two and three EIs were calculated.

RESULTS

One hundred and sixty-one patients (total number =210) were healed after 1 injection, 28 after 2 and 4 after 3 with a global success rate of 91.90%. Recurrence rate is higher in patients older than 3 years old and with IV and V reflux grade. Even if 67.7% of recurrent VUR after one injection was symptomatic, diagnosis of recurrences after multiple EI was mainly radiological. Only 8% of the patients underwent EI need an anti-reflux surgery.

CONCLUSIONS

Thanks to its low costs and the acceptable recurrence rate, Deflux EI should be proposed as the first therapeutic approach for children affected by VUR, especially in those with low and moderate grades of VUR. Multiple injections could be contraindicated only in older children thank 1 year with high-grade VUR (IV symptomatic and V grade).

摘要

背景

内镜注射(EI)是治疗儿童膀胱输尿管反流(VUR)的一种安全方法,但复发情况并不少见。本研究旨在表明,即使出现复发,多次内镜注射是否仍是最佳的一线治疗方法。

方法

纳入所有患有原发性VUR、接受过至少一次内镜注射且随访至少5年的患者。分析所有一般数据。计算一次、两次和三次内镜注射后的复发率。

结果

161例患者(总数=210)在1次注射后治愈,28例在2次注射后治愈,4例在3次注射后治愈,总体成功率为91.90%。3岁以上且反流分级为IV级和V级的患者复发率更高。即使一次注射后67.7%的复发性VUR有症状,但多次内镜注射后复发的诊断主要依靠影像学检查。仅8%接受内镜注射的患者需要进行抗反流手术。

结论

由于成本低且复发率可接受,Deflux内镜注射应作为VUR患儿的首选治疗方法,尤其是低级别和中级别VUR患儿。仅对于1岁以上患有高级别VUR(IV级有症状和V级)的大龄儿童,多次注射可能是禁忌的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce3a/11399022/85af169e70b6/tau-13-08-1446-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce3a/11399022/cf5909fe574e/tau-13-08-1446-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce3a/11399022/a10b7038547b/tau-13-08-1446-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce3a/11399022/aeffff164d17/tau-13-08-1446-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce3a/11399022/85af169e70b6/tau-13-08-1446-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce3a/11399022/cf5909fe574e/tau-13-08-1446-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce3a/11399022/a10b7038547b/tau-13-08-1446-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce3a/11399022/aeffff164d17/tau-13-08-1446-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce3a/11399022/85af169e70b6/tau-13-08-1446-f4.jpg

相似文献

1
Recurrence of vesico-ureteral reflux in children: is still the endoscopic injection the best option?儿童膀胱输尿管反流复发:内镜注射仍是最佳选择吗?
Transl Androl Urol. 2024 Aug 31;13(8):1446-1454. doi: 10.21037/tau-24-76. Epub 2024 Aug 26.
2
Patients with a history of infection and voiding dysfunction are at risk for recurrence after successful endoscopic treatment of vesico ureteral reflux and deserve long-term follow up.有感染病史和排尿功能障碍的患者在膀胱输尿管反流内镜治疗成功后有复发风险,值得长期随访。
Urol Ann. 2012 Jan;4(1):19-23. doi: 10.4103/0974-7796.91616.
3
Outcomes of complex robot-assisted laparoscopic ureteral reimplantation after failed ipsilateral endoscopic treatment of vesicoureteral reflux.复杂性机器人辅助腹腔镜输尿管再植术治疗同侧内镜治疗失败的膀胱输尿管反流的结果。
J Pediatr Urol. 2021 Aug;17(4):547.e1-547.e6. doi: 10.1016/j.jpurol.2021.05.029. Epub 2021 Jun 9.
4
Comparison of results of endoscopic correction of vesicoureteral reflux in children using two bulking substances: Dextranomer/hyaluronic acid copolymer (Deflux) versus polyacrylate-polyalcohol copolymer (Vantris).使用两种填充物质对儿童膀胱输尿管反流进行内镜矫正的结果比较:葡聚糖/透明质酸共聚物(Deflux)与聚丙烯酸-多元醇共聚物(Vantris)。
J Pediatr Urol. 2016 Aug;12(4):256.e1-4. doi: 10.1016/j.jpurol.2016.04.006. Epub 2016 May 10.
5
High-grade vesicoureteral reflux in infants: Our experience with endoscopic subureteric injections.婴儿高级别膀胱输尿管反流:我们经内镜下输尿管内注射治疗的经验。
Urologia. 2022 Feb;89(1):120-125. doi: 10.1177/0391560320966187. Epub 2020 Oct 16.
6
Proprietary non-animal stabilized hyaluronic acid/dextranomer gel (NASHA/Dx) for endoscopic treatment of grade IV vesicoureteral reflux: Long-term observational study.用于内镜治疗IV级膀胱输尿管反流的专利非动物稳定化透明质酸/葡聚糖凝胶(NASHA/Dx):长期观察性研究。
J Pediatr Urol. 2020 Jun;16(3):328.e1-328.e9. doi: 10.1016/j.jpurol.2020.04.008. Epub 2020 Apr 13.
7
What are the predictive factors leading to ureteral obstruction following endoscopic correction of VUR in the pediatric population?哪些预测因素导致儿科人群内镜下治疗反流性输尿管肾盂积水(VUR)后发生输尿管梗阻?
J Pediatr Urol. 2018 Dec;14(6):538.e1-538.e7. doi: 10.1016/j.jpurol.2018.04.021. Epub 2018 May 25.
8
Endoscopic treatment of vesico-ureteral reflux: Experience of 99 ureteric moieties.膀胱输尿管反流的内镜治疗:99个输尿管节段的经验
J Indian Assoc Pediatr Surg. 2013 Oct;18(4):133-5. doi: 10.4103/0971-9261.121112.
9
[Treatment of vesicouretheral reflux in pediatric patients].[小儿膀胱输尿管反流的治疗]
Vojnosanit Pregl. 2009 May;66(5):388-94. doi: 10.2298/vsp0905388g.
10
Comparing treatment modalities for transplant kidney vesicoureteral reflux in the pediatric population.比较小儿肾移植后膀胱输尿管反流的治疗方式。
J Pediatr Urol. 2018 Dec;14(6):554.e1-554.e6. doi: 10.1016/j.jpurol.2018.07.006. Epub 2018 Jul 24.

本文引用的文献

1
Endoscopic injection of bulking agents in pediatric vesicoureteral reflux: a narrative review of the literature.内镜下注射填充剂治疗小儿膀胱输尿管反流:文献综述。
Pediatr Surg Int. 2023 Feb 18;39(1):133. doi: 10.1007/s00383-023-05426-w.
2
Comparative study of open, laparoscopic and endoscopic treatments of intermediate grade vesicoureteral reflux in children.儿童中度膀胱输尿管反流开放手术、腹腔镜手术及内镜治疗的对比研究
Surg Endosc. 2023 Apr;37(4):2682-2687. doi: 10.1007/s00464-021-08985-y. Epub 2022 Nov 22.
3
A systematic review & meta-analysis comparing outcomes of endoscopic treatment of primary vesico ureteric reflux in children with polyacrylate poly alcohol copolymer versus dextranomer hyaluranic acid.
系统评价与荟萃分析比较了聚丙烯酸酯聚醇共聚物与葡聚糖多聚体透明质酸治疗儿童原发性膀胱输尿管反流的疗效。
J Pediatr Surg. 2022 Nov;57(11):683-689. doi: 10.1016/j.jpedsurg.2022.01.025. Epub 2022 Feb 1.
4
Endoscopic treatment of primary vesicoureteral reflux in children with two different bulking agents, high success and low complication rates: Comparison of Dexell and Vantris.内镜下使用两种不同的填充剂治疗儿童原发性膀胱输尿管反流:Dexell 和 Vantris 的高成功率和低并发症率比较。
Actas Urol Esp (Engl Ed). 2021 Oct;45(8):545-551. doi: 10.1016/j.acuroe.2021.07.002. Epub 2021 Sep 12.
5
Current trends in 2021 in surgical management of vesico-ureteral reflux in pediatric patients: results of a multicenter international survey on 552 patients.2021年小儿膀胱输尿管反流手术治疗的当前趋势:一项针对552例患者的多中心国际调查结果
Minerva Urol Nephrol. 2023 Feb;75(1):106-115. doi: 10.23736/S2724-6051.21.04430-X. Epub 2021 Jun 11.
6
Contemporary Management of Urinary Tract Infection in Children.儿童尿路感染的当代管理
Pediatrics. 2021 Feb;147(2). doi: 10.1542/peds.2020-012138.
7
Urinary biomarkers as point-of-care tests for predicting progressive deterioration of kidney function in congenital anomalies of kidney and urinary tract: trefoil family factors (TFFs) as the emerging biomarkers.尿生物标志物作为即时检测预测肾和尿路先天性异常肾功能进行性恶化的指标:三叶因子家族(TFFs)作为新兴的生物标志物。
Pediatr Nephrol. 2021 Jun;36(6):1465-1472. doi: 10.1007/s00467-020-04841-8. Epub 2021 Jan 8.
8
Evaluation of Urinary Neutrophil Gelatinase-associated Lipocalin as a Biomarker in Pediatric Vesicoureteral Reflux Assessment.评价尿中性粒细胞明胶酶相关脂质运载蛋白在小儿膀胱输尿管反流评估中的生物标志物作用。
Iran J Kidney Dis. 2020 Sep;14(5):373-379.
9
Proprietary non-animal stabilized hyaluronic acid/dextranomer gel (NASHA/Dx) for endoscopic treatment of grade IV vesicoureteral reflux: Long-term observational study.用于内镜治疗IV级膀胱输尿管反流的专利非动物稳定化透明质酸/葡聚糖凝胶(NASHA/Dx):长期观察性研究。
J Pediatr Urol. 2020 Jun;16(3):328.e1-328.e9. doi: 10.1016/j.jpurol.2020.04.008. Epub 2020 Apr 13.
10
Endoscopic Management of Vesicoureteral Reflux and Long-term Follow-up.膀胱输尿管反流的内镜治疗及长期随访
Indian Pediatr. 2018 Dec 15;55(12):1046-1049.